Completed NA INTERVENTIONAL 2-arm NCT01033799

Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers

Sponsor: Danone Global Research & Innovation Center

Conditions Bronchitis Gastroenteritis Healthy Subjects Infectious Diseases Influenza Otitis Pneumonia Respiratory Tract Infections Sinusitis Sore Throat

Interventions Fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel®) Non fermented dairy product (control)

Updated 7 times since 2017 Last updated: Jan 18, 2017 Started: Oct 31, 2006 Primary completion: Apr 30, 2007 Completion: Aug 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01033799, this NA trial focuses on Bronchitis and Gastroenteritis and remains completed. Sponsored by Danone Global Research & Innovation Center, it has been updated 7 times since 2006, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Jan 2025 — Present [monthly]

Completed NA
Sep 2024 — Jan 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Danone Global Research & Innovation Center

Data source: Danone Global Research & Innovation Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• München, Germany